Details for Patent: 11,559,535

« Back to Dashboard

Which drugs does patent 11,559,535 protect, and when does it expire?

Patent 11,559,535 protects FUROSCIX READYFLOW (AUTOINJECTOR) and is included in one NDA.

This patent has twenty-four patent family members in fourteen countries.

Summary for Patent: 11,559,535

Title:	Concentrated liquid pharmaceutical formulations of furosemide
Abstract:	Disclosed herein, in part, are liquid pharmaceutical formulations comprising furosemide or a pharmaceutically acceptable salt thereof, one or more pharmaceutically acceptable excipients, and a pharmaceutically acceptable buffer. Methods of treating congestion, edema, fluid overload, or hypertension in a patient in need thereof are also provided.
Inventor(s):	Alfredo Grossi, Britt Kostraba, Olatokumbo O. Luca Ogunleye, Shannon Terry, Franciscus KOPPENHAGEN
Assignee:	ScPharmaceuticals Inc
Application Number:	US17/817,731
Patent Claim Types: see list of patent claims	Formulation; Compound;

Drugs Protected by US Patent 11,559,535

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Scpharmaceuticals	FUROSCIX READYFLOW (AUTOINJECTOR)	furosemide	SOLUTION;SUBCUTANEOUS	209988-002	Jul 23, 2026		RX	Yes	Yes	11,559,535		Y

International Family Members for US Patent 11,559,535

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2020214314
Australia	2025283539
Brazil	112021014637
Canada	3128033
China	113747881